Skip to Main Content

Author Details

Craig A Elmets
University of Alabama
1979
269
61
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37821054Response to letter to the editor "It's time to consider a new topical algorithm for psoriasis".J Am Acad Dermatol2024
37821054Response to letter to the editor "It's time to consider a new topical algorithm for psoriasis".J Am Acad Dermatol2024
36436565Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics.J Biol Chem2023
36436582Quantitative analysis of restricted metals and metalloids in tattoo inks: A systematic review and meta-analysis.Chemosphere2023
36436565Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics.J Biol Chem2023
38011564Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa.Proc Natl Acad Sci U S A2023
37961206NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2.bioRxiv2023
37332597Mechanism underlying follicular hyperproliferation and oncogenesis in hidradenitis suppurativa.iScience2023
37961206NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2.bioRxiv2023
38011564Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa.Proc Natl Acad Sci U S A2023
37332597Mechanism underlying follicular hyperproliferation and oncogenesis in hidradenitis suppurativa.iScience2023
36436582Quantitative analysis of restricted metals and metalloids in tattoo inks: A systematic review and meta-analysis.Chemosphere2023
35027465The Challenge of Melanoma Chemoprevention.Cancer Prev Res (Phila)2022
35775377CYP11A1â¿¿derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.Int J Oncol2022
35695215Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma.Dermatol Ther2022
36318154Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.J Med Chem2022
36317800Neuroendocrine signaling in the skin with a special focus on the epidermal neuropeptides.Am J Physiol Cell Physiol2022
35301634Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs.Inflammation2022
35027465The Challenge of Melanoma Chemoprevention.Cancer Prev Res (Phila)2022
35163747Type I Interferons Enhance the Repair of Ultraviolet Radiation-Induced DNA Damage and Regulate Cutaneous Immune Suppression.Int J Mol Sci2022
35131152Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling.Semin Cell Dev Biol2022
35775377CYP11A1â¿¿derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.Int J Oncol2022
35695215Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma.Dermatol Ther2022
36318154Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.J Med Chem2022
36317800Neuroendocrine signaling in the skin with a special focus on the epidermal neuropeptides.Am J Physiol Cell Physiol2022
35163747Type I Interferons Enhance the Repair of Ultraviolet Radiation-Induced DNA Damage and Regulate Cutaneous Immune Suppression.Int J Mol Sci2022
35131152Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling.Semin Cell Dev Biol2022
35301634Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs.Inflammation2022
32790578Moving Immune Therapy Forward Targeting TME.Physiol Rev2021
33484768Dietary table grape protects against ultraviolet photodamage in humans: 2. molecular biomarker studies.J Am Acad Dermatol2021
33484767Dietary table grape protects against ultraviolet photodamage in humans: 1. clinical evaluation.J Am Acad Dermatol2021
33559857IL-23 and the Tumor Microenvironment.Adv Exp Med Biol2021
33716049The significance of CYP11A1 expression in skin physiology and pathology.Mol Cell Endocrinol2021
33148679Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.Cancer Prev Res (Phila)2021
32738429Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.J Am Acad Dermatol2021
33283918Toll-like receptor-4 deficiency inhibits ultraviolet radiation-induced tumor development by modulation of immune and inflammatory responses.Mol Carcinog2021
32790578Moving Immune Therapy Forward Targeting TME.Physiol Rev2021
34771569Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice.Cancers (Basel)2021
33716049The significance of CYP11A1 expression in skin physiology and pathology.Mol Cell Endocrinol2021
33484768Dietary table grape protects against ultraviolet photodamage in humans: 2. molecular biomarker studies.J Am Acad Dermatol2021
33484767Dietary table grape protects against ultraviolet photodamage in humans: 1. clinical evaluation.J Am Acad Dermatol2021
33559857IL-23 and the Tumor Microenvironment.Adv Exp Med Biol2021
34771569Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice.Cancers (Basel)2021
33283918Toll-like receptor-4 deficiency inhibits ultraviolet radiation-induced tumor development by modulation of immune and inflammatory responses.Mol Carcinog2021
33148679Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.Cancer Prev Res (Phila)2021
32738429Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.J Am Acad Dermatol2021
32246968No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.J Am Acad Dermatol2020
31970282Idiopathic extensive acanthosis nigricans with a variant of the epidermal growth factor receptor.JAAD Case Rep2020
32246968No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.J Am Acad Dermatol2020
32119894Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.J Am Acad Dermatol2020
  • 1 - 50 of 538

Recommended Authors

Jennifer L Strunck
Oregon Health & Science University
Career Start Year 2015
Number of shared co-authors 0
Allison K Truong
David Geffen School of Medicine, University of California los angeles
Career Start Year 2011
Number of shared co-authors 0
Beatrice Dyring-Andersen
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year 2011
Number of shared co-authors 0
Helen T Michael
National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 0
Marija Buljan
Sestre milosrdnice University Hospital Centre
Career Start Year 2005
Number of shared co-authors 0
Shadmehr Demehri
Massachusetts General Hospital and Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Dakshayani Lomada
Yogi Vemana University
Career Start Year 2004
Number of shared co-authors 0
Lee Wheless
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 1999
Number of shared co-authors 0
Vivian Lee
Keck School of Medicine of USC, University of Southern
Career Start Year 1999
Number of shared co-authors 0
Rubeta N Matin
Oxford University Hospitals NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 1
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Thomas J Hornyak
University of Maryland School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Michael Binder
Medical University of Vienna
Career Start Year 1989
Number of shared co-authors 0
Fredika M Robertson
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
Robert Sarkany
St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1985
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 1
Molly Kulesz-Martin
Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 0
Celia Moss
King's College London
Career Start Year 1980
Number of shared co-authors 0
Evelyn Flynn
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0
Carol L Sabourin
Battelle Memorial Institute
Career Start Year 1978
Number of shared co-authors 0
Michael J Connor
Emory University School of Medicine
Career Start Year 1977
Number of shared co-authors 0
Dennis P West
Feinberg School of Medicine, Northwestern University
Career Start Year 1977
Number of shared co-authors 1
Scott M Lippman
Moores Cancer Center, university of california san diego
Career Start Year 1977
Number of shared co-authors 0
Edward C De Fabo
The George Washington University Medical Center
Career Start Year 1976
Number of shared co-authors 3
Frances P Noonan
The George Washington University Medical Center
Career Start Year 1974
Number of shared co-authors 2
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Career Start Year 1972
Number of shared co-authors 2
Johan Moan
Oslo University Hospital
Career Start Year 1971
Number of shared co-authors 0
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 1

Collaborators

Mohammad Athar
University of Alabama at Birmingham
Co-authored papers 67
Hui Xu
Co-authored papers 31
Boni E Elewski
Co-authored papers 21
Farrukh Afaq
Co-authored papers 20
Zhiping Weng
University of Massachusetts Medical School
Co-authored papers 14
Sandeep C Chaudhary
Co-authored papers 14
Laura Timares
Co-authored papers 14
Levy Kopelovich
Co-authored papers 13
Ritesh K Srivastava
Co-authored papers 10
David R Bickers
Co-authored papers 10
Changzhao Li
Co-authored papers 10
Jianmin Xu
Co-authored papers 9
Jessy S Deshane
Co-authored papers 8
Andrzej T Slominski
University of Alabama at Birmingham
Co-authored papers 8
Venkatram R Atigadda
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 7
Aadithya Arumugam
Co-authored papers 7
Kristopher McKay
Co-authored papers 6
Chander Raman
University of Alabama at Birmingham
Co-authored papers 6
Allen S W Oak
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 6
Tripti Singh
Co-authored papers 6
Anton M Jetten
National Institutes of Health
Co-authored papers 5
Robert C Tuckey
The University of Western Australia
Co-authored papers 5
Radomir M Slominski
University of Alabama at Birmingham
Co-authored papers 4
Mahendra Kashyap
Co-authored papers 4
Zorica Janjetovic
University of Alabama at Birmingham
Co-authored papers 3
Tae-Kang Kim
University of Alabama at Birmingham
Co-authored papers 3
Kayla F Goliwas
Co-authored papers 3
Bharat Mishra
Co-authored papers 2
Puneet Kapur
Co-authored papers 2
Anupam Agarwal
Co-authored papers 2
Release 1.2